Cargando…
Clofarabine desensitization: A case report: Leukemia research reports
We describe a relapsed AML patient who had two prior severe reactions to clofarabine involving rigors, emesis, tachycardia, hypotension, and acute kidney injury. Given previous prolonged remission achieved with clofarabine and cytarabine therapy years prior, rechallenge was undertaken upon discovery...
Autores principales: | Hayes, Sarah M., Wasko, Justin A., Warlick, Erica Dahl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312643/ https://www.ncbi.nlm.nih.gov/pubmed/28229039 http://dx.doi.org/10.1016/j.lrr.2017.02.001 |
Ejemplares similares
-
Use of clofarabine for acute childhood leukemia
por: Pession, A, et al.
Publicado: (2010) -
Treating refractory leukemias in childhood, role
of clofarabine
por: Harned, Theresa M, et al.
Publicado: (2008) -
Clofarabine Experience in Children with Multi-Relapsed Acute Leukemia
por: Karakaş, Zeynep, et al.
Publicado: (2014) -
Patient-Level Meta-analysis of Clofarabine in Acute Lymphoblastic Leukemia
por: Jeha, Sima, et al.
Publicado: (2023) -
Successful combination chemotherapy involving clofarabine, cyclophosphamide, and etoposide for pediatric relapsed acute myeloid leukemia: A case report
por: Fujita, Sachio, et al.
Publicado: (2021)